An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia
1 other identifier
observational
330
1 country
10
Brief Summary
This study is aimed to collect the following Serbia-specific epidemiology data on hypercholesterolemia: patents characteristics, patients' management/treatment and physicians' standard practice. In addition, the aim is to determine the proportion of patients on lipid-lowering pharmacological treatment who have reached the LDL-C and HDL-C treatment goals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2010
Shorter than P25 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2010
CompletedFirst Posted
Study publicly available on registry
September 21, 2010
CompletedStudy Start
First participant enrolled
December 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedNovember 8, 2011
November 1, 2011
10 months
September 20, 2010
November 7, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines
24 weeks
Secondary Outcomes (3)
Proportion of patients on lipid-lowering pharmacological treatment reaching the non HDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines;
24 weeks
Physicians' standard practice in managing patients with hypercholesterolemia (by using physicians' questionnaire);
24 weeks
Local epidemiological date on patients with hypercholesterolemia (Demographic Data; Hypercholesterolemia management data: treatment, treatment changes)
24 weeks
Study Arms (1)
1
Patients with hypercholesterolemia
Eligibility Criteria
Speciality care clinics
You may qualify if:
- Patients with hypercholesterolemia currently receiving a lipid lowering agent
You may not qualify if:
- Pregnancy and lactation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (10)
Research Site
Belgrade, Serbia
Research Site
Čačak, Serbia
Research Site
Kamenitz, Serbia
Research Site
Kragujevac, Serbia
Research Site
Niš, Serbia
Research Site
Niška Banja, Serbia
Research Site
Pančevo, Serbia
Research Site
Požarevac, Serbia
Research Site
Sombor, Serbia
Research Site
Užice, Serbia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prof.Dr Miodrag Ostojic
Division of Cardiology-Clinical Centre of Serbia-Belgrade
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 20, 2010
First Posted
September 21, 2010
Study Start
December 1, 2010
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
November 8, 2011
Record last verified: 2011-11